Nucleic acid therapeutics: a work in progress.
作者信息
Opalinska Joanna B, Gewirtz Alan M
机构信息
Department of Hematology, Pommeranian Medical Academy, Szczecin, Poland.
出版信息
Curr Opin Investig Drugs. 2002 Jun;3(6):928-33.
PMID:12137416
Abstract
摘要
相似文献
1
Nucleic acid therapeutics: a work in progress.
Curr Opin Investig Drugs. 2002 Jun;3(6):928-33.
2
Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA.
Expert Opin Drug Deliv. 2005 Jan;2(1):3-28. doi: 10.1517/17425247.2.1.3.
3
Nucleic acid therapeutics for hematologic malignancies--theoretical considerations.
Ann N Y Acad Sci. 2006 Oct;1082:124-36. doi: 10.1196/annals.1348.002.
4
Perspectives on chemistry and therapeutic applications of Locked Nucleic Acid (LNA).
Chem Rev. 2007 Nov;107(11):4672-97. doi: 10.1021/cr050266u. Epub 2007 Oct 18.
5
Antisense DNAs as targeted therapeutics for cancer: no longer a dream.
Curr Opin Investig Drugs. 2002 Jun;3(6):934-9.
6
AEG-35156, an antisense oligonucleotide against X-linked inhibitor of apoptosis for the potential treatment of cancer.
Curr Opin Investig Drugs. 2008 Jun;9(6):638-46.
7
[Basics of antisense oligonucleotide therapy and current therapeutical strategies in urology].
Aktuelle Urol. 2003 Dec;34(7):458-68. doi: 10.1055/s-2003-45263.
8
Progress in the development of nucleic acid therapeutics for cancer.
Cancer Biol Ther. 2004 Jan;3(1):4-12. doi: 10.4161/cbt.3.1.517. Epub 2004 Jan 18.
9
Enhanced inhibition of transcription start by targeting with 2'-OMe pentaribonucleotides comprising locked nucleic acids and intercalating nucleic acids.
Chembiochem. 2005 Jul;6(7):1181-4. doi: 10.1002/cbic.200400457.
10
Antisense strategies for oncogene inactivation.
Semin Oncol. 2005 Dec;32(6):563-72. doi: 10.1053/j.seminoncol.2005.09.003.
Zotero 插件